France: In a recent pilot study, researchers are investigating the efficacy of phenolization as a treatment for sinus tracts ...

Patients with hidradenitis suppurativa experience knowledge gaps on effective treatments and addressing these gaps could help ...

The Global Healthy Living Foundation (GHLF) announced today the launch of Your Interactive Patient Guide to Hidradenitis Suppurativa (HS), a groundbreaking resource designed to empower individuals ...

The guidelines are a first-of-its-kind effort to establish recommendations for the medical management of HS in seven different scenarios: Pregnancy, breastfeeding, pediatrics, malignancy, tuberculosis ...

The following is a summary of “Exploring itch in hidradenitis suppurativa with lessons from atopic dermatitis and psoriasis,” published in the January 2025 issue of Dermatology by Trupiano et al. Itch ...

Hidradenitis Suppurativa [HS] is characterized as a chronic skin disorder where the skin has the formation of painful bumps and abscesses that drain pus. However, it is important to keep in mind ...

USA: A recent post hoc analysis of two randomized clinical trials has provided insight into the role of C-reactive protein (CRP) as a potential biomarker for predicting the response to adalimumab in ...

A cohort study suggests that people with hidradenitis suppurativa (HS) have twice the incidence of noninfectious uveitis (NIU) as controls, an association that remained significant after adjusting ...

Abdominal pain is considered chronic if it lasts for more than three months. The pain may be constant or it can come and go over the three-month period or longer. There are many health conditions, ...

I was diagnosed with hidradenitis suppurativa (HS). It’s an autoinflammatory condition that causes skin lesions, severe fatigue and chronic pain and is implicated in a number of comorbidities ...

NICE is unable to make a recommendation about the use in the NHS of bimekizumab (Bimzelx) for treating moderate to severe hidradenitis suppurativa in adults. This is because UCB Pharma withdrew from ...